Case Report
Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
Figure 2
Case 2. Optical coherence tomographic images and fundus photographs showing the central retinal thickness (CRT) pre (A, B) and at 2 months (M) (C, D), 3 M (E, F), 6 M (G, H), and 12 M (I, J) after commencing the oral sodium-glucose cotransporter 2 inhibitor (SGLT2i). A sub-Tenon injection of triamcinolone acetonide (STTA) was administered in her right eye at eight months.